Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$517M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$516M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$306M |
| 4 |
Meta Platforms (Facebook)
META
|
+$296M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$441M |
| 2 |
Duke Energy
DUK
|
+$407M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.71% |
| 2 | Financials | 4.45% |
| 3 | Healthcare | 3.9% |
| 4 | Communication Services | 2.83% |
| 5 | Consumer Discretionary | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Neurocrine Biosciences
NBIX
$17.1B
| $3.9M | ﹤0.01% |
100,615
+93,196
| +1,256% | +$4.22M |
|
1552
3D Systems Corp
DDD
$441M
| $3.88M | ﹤0.01% |
291,972
+37,771
| +15% | +$554K |
|
1553
CALL
Tapestry
TPR
$31.6B
| $3.86M | ﹤0.01% |
110,300
+4,600
| +4% | +$168K |
|
1554
PUT
Becton Dickinson
BDX
$46.7B
| $3.86M | ﹤0.01% |
23,883
+18,143
| +316% | +$3.01M |
|
|
ICPT
1555
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.86M | ﹤0.01% |
35,500
+27,300
| +333% | +$3.25M |
|
1556
PUT
Ralph Lauren
RL
$22.6B
| $3.84M | ﹤0.01% |
42,500
+5,500
| +15% | +$559K |
|
|
UN
1557
PUT
DELISTED
Unilever NV New York Registry Shares
UN
| $3.84M | ﹤0.01% |
+93,500
| New | +$3.87M |
|
1558
iShares MSCI Germany ETF
EWG
$1.6B
| $3.83M | ﹤0.01% |
144,493
-14,779
| -9% | -$380K |
|
1559
Western Alliance Bancorporation
WAL
$8.93B
| $3.82M | ﹤0.01% |
78,406
-8
| -0% | -$344 |
|
|
RSX
1560
DELISTED
VanEck Russia ETF
RSX
| $3.82M | ﹤0.01% |
179,933
+36,831
| +26% | +$714K |
|
1561
Universal Health Services
UHS
$10.5B
| $3.81M | ﹤0.01% |
35,818
+5,425
| +18% | +$642K |
|
1562
CALL
Corning
GLW
$121B
| $3.81M | ﹤0.01% |
156,800
-67,900
| -30% | -$1.61M |
|
1563
Acadia Pharmaceuticals
ACAD
$4.46B
| $3.81M | ﹤0.01% |
131,946
+46,230
| +54% | +$1.22M |
|
|
MMP
1564
CALL
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $3.8M | ﹤0.01% |
50,300
+7,700
| +18% | +$539K |
|
1565
CALL
DigitalBridge
DBRG
$2.93B
| $3.8M | ﹤0.01% |
63,700
+1,200
| +2% | +$67.7K |
|
1566
Ball Corp
BALL
$17.5B
| $3.79M | ﹤0.01% |
101,084
-132,356
| -57% | -$5.12M |
|
|
SPLK
1567
CALL
DELISTED
Splunk Inc
SPLK
| $3.79M | ﹤0.01% |
74,100
+18,000
| +32% | +$1.04M |
|
|
SINA
1568
CALL
DELISTED
Sina Corp
SINA
| $3.78M | ﹤0.01% |
62,200
-18,800
| -23% | -$1.35M |
|
1569
Ametek
AME
$55.7B
| $3.78M | ﹤0.01% |
77,669
+16,361
| +27% | +$775K |
|
1570
CALL
Truist Financial
TFC
$63.3B
| $3.78M | ﹤0.01% |
80,300
+45,700
| +132% | +$1.94M |
|
1571
Avery Dennison
AVY
$13.2B
| $3.77M | ﹤0.01% |
53,752
+33,174
| +161% | +$2.41M |
|
1572
Abercrombie & Fitch
ANF
$4.69B
| $3.77M | ﹤0.01% |
314,607
+23,942
| +8% | +$356K |
|
1573
PUT
Canadian Pacific Kansas City
CP
$78.1B
| $3.77M | ﹤0.01% |
132,000
-26,000
| -16% | -$768K |
|
1574
PUT
Banc of California
BANC
$3.07B
| $3.77M | ﹤0.01% |
+217,000
| New | +$3.33M |
|
1575
CALL
Thermo Fisher Scientific
TMO
$216B
| $3.74M | ﹤0.01% |
26,500
-81,100
| -75% | -$12M |
|
Similar funds
Barclays's Q4 2016 Portfolio in Review
As of Q4 2016, Barclays held 7,178 positions worth $92.5B, up 2.7% from $90.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays's Q4 2016 filing shows 490 new, 3,383 increased, 2,405 reduced and 438 closed positions. Its largest new stake was Howmet Aerospace: 1,639,920 shares worth $23.3M. The largest sale was Procter & Gamble, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
- Barclays's largest Q4 2016 buy was Howmet Aerospace: 1,639,920 shares worth $23.3M.
- Barclays added most to State Street Technology Select Sector SPDR ETF in Q4 2016, an estimated $517M increase.
- Barclays's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $441M.
- Barclays fully exited LinkedIn Corporation in Q4 2016, selling an estimated $223M.
- Barclays's ten largest holdings make up 34% of its $92.5B portfolio in Q4 2016.
- Barclays opened 490 new positions and closed 438 in Q4 2016.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $92.5B.
Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.